| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | Acalabrutinib |
|---|
| Description | Purity >95%. Acalabrutinib is an irreversible inhibitor of Bruton's tyrosine kinase (BTK). It can dose-dependently inhibit B cell receptor signaling in primary chronic lymphocytic leukemia cells. In kinase-inhibition assays, acalabrutinib was more selective than ibrutinib for inhibiting BTK and did not inhibit EGFR, Itk, or Txk signaling. |
|---|
| Size | n/a |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 4-[8-amino-3-[(2S)-1-(1-oxo-2-butyn-1-yl)-2-pyrrolidinyl]imidazo[1,5-a]pyrazin-1-yl]-N-2-pyridinyl-benzamide, ACP-196 |
|---|
| Gene, Accession, CAS # | CAS: 1420477-60-6 |
|---|
| Catalog # | LS-H6386 |
|---|
| Price | |
|---|
| Order / More Info | Acalabrutinib from LIFESPAN BIOSCIENCES INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|